Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

GHN Pharma AB

Closing information (x1000 DKK)

Closing information 2024/12 (consolidated) 2023/12 2022/12
Turnover 105,191 Less Arrow 1,341 Less Arrow 198
Financial expenses 113 Less Arrow 7 More Arrow 1,628
Earnings before taxes 18,925 Less Arrow 3,553 Less Arrow -1,988
EBITDA 13,126 Less Arrow -40 Less Arrow -1,346
Total assets 111,431 Less Arrow 64,175 Less Arrow 60,555
Current assets 45,898 Less Arrow 1,994 Less Arrow 1,606
Current liabilities 20,294 Less Arrow 568 Less Arrow 140
Equity capital 84,989 Less Arrow 63,607 Less Arrow 60,414
- share capital 268 More Arrow 277 Less Arrow 275
Employees (average) 7 Less Arrow 2 Equal arrow 2

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 2022/12
Solvency 76.3% More Arrow 99.1% More Arrow 99.8%
Turnover per employee 15,027 Less Arrow 670 Less Arrow 99
Profit as a percentage of turnover 18.0% More Arrow 265.0% Less Arrow -1004.0%
Return on assets (ROA) 17.1% Less Arrow 5.5% Less Arrow -0.6%
Current ratio 226.2% More Arrow 351.1% More Arrow 1147.1%
Return on equity (ROE) 22.3% Less Arrow 5.6% Less Arrow -3.3%
Change turnover
Change turnover % 575% Less Arrow -95%
Chg. No. of employees
Chg. No. of employees % 0% Equal arrow 0%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.